WE’RE ALREADY DELIVERING
WITH OUR FIRST INVESTMENT (2019) IN COPENHAGEN BASED OCTARINE BIO
OUR FIRST INVESTMENT: OCTARINE BIO
- Company Octarine
- Investment Area Emerging Markets, Derived Products and Circular Economy
- Location Copenhagen, Denmark
- Website: https://octarinebio.com/
Octarine harnesses synthetic biology to develop functionally superior cannabinoid and psilocybin derivatives.
Our mission is to improve the health and well-being of people worldwide
Using our unique biosynthetic platform we engineer microorganisms to produce a range of natural and novel cannabinoid and psilocybin derived molecules with improved pharmacokinetic and therapeutic properties.
OUR SECOND INVESTMENT: HERBOLEA
- Company Herbolea
- Investment Area Ecosystem Building
- Location Florence, Italy
- Website: https://www.herbolea.com
Herbolea develops and licenses proprietary, solvent-less technologies to transform botanicals into superior quality products.